NeoChord
PrivateLast Round
Convertible Debt
Feb 27, 2025
Total Funding Raised
$70.59M
Company Overview
NeoChord is a medical technology company that develops minimally invasive, beating-heart mitral valve repair tools for patients suffering from mitral valve regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoChord Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeoChord Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Feb 27, 2025 | ||||
| Series D Extension | Apr 23, 2019 | ||||
| Series D | Nov 5, 2018 | ||||
| Series C | Jun 9, 2015 | ||||
| Debt | Oct 24, 2013 | ||||
Debt | Sep 9, 2013 |
Key People
Founding team and executive leadership
NeoChord Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series D Extension, Series C, Series D |
| Square 1 Bank | Debt |
| Heron Capital | Series A, Series C, Series B |
| U.S. Venture Partners | Series D Extension, Series D |
| Baird Capital | Series C, Series D |
| Cedar Point Capital | Series A |
| Hopen Life Science Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2011
$2M debt round completed.
NeoChord Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeoChord's valuation, stock price, and market status.